This study aims to address this gap by investigating the expression patterns of CXCR5 and LAG‐3 on CD8+ T cells and exploring their clinical significance in the prognosis and treatment of DLBCL. The gene discussed is CXCR5; the disease is diffuse large B-cell lymphoma.